|
Jan O Johansson, MD, PhD, Artery Therapeutics, Inc, San Ramon, CA, USA; Hussein N. Yassine, MD, Keck School of Medicine at University of Southern California, Los Angeles, CA, USA; Ori Liraz, PhD, Tel Aviv University, Tel Aviv, Israel; Henrik Zetterberg, MD PhD, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden; The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, United Kingdom; Ana Valencia - Olvera, PhD, University of Ilinois at Chicago - College of Medicine, Chicago, IL, USA; Mary Jo Ladu, PhD, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA and Daniel M Michaelson, PhD, The Sagol School of Neuroscience, Tel Aviv University, Israel, Tel Aviv, Israel
|